Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
about
Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective StudiesThe effectiveness of tacrolimus and minidose methotrexate in the prevention of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in children: a single-center study in KoreaFactors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantationSignificant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.Prevention and treatment of acute GvHD.Tacrolimus in the treatment of ocular diseases.Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT.High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers.Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis iOutcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients.Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation.Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.
P2860
Q35703480-58F2B27F-3BD4-46A2-AE87-FFD11F2F57A3Q36074018-5864A7EF-8B60-4BB5-87FB-1D65EB6257E5Q36418533-F4059150-1B55-4281-BBF7-DEE7BF7CD427Q36951734-B626BDF8-687C-40BB-8DF4-234E37F4204DQ37188487-F2ACED64-950A-44D5-8E72-1B1888E6956EQ37858514-15CB402C-E707-477A-AF8F-99241C18425EQ38011573-F9E2A291-9818-40B2-8163-C76678027A4FQ40361644-CCAE585E-B7C2-4074-A8B1-C99698CA49B2Q41434713-566E1EA1-E154-4BFC-A731-59A37BEC76F7Q44074090-EF3CE26B-A90B-4F09-ABA9-27F94ED01E03Q44499723-60E82208-78FA-42FA-AB34-F526A5DF340AQ47140612-69CD7C39-4C01-4945-8542-F8D72A1AB2F3Q49074524-FC83E9B1-44A2-4281-828E-AD2A19599BF3Q53175337-9E7A6AB7-72D9-4A94-8BE8-B799E7FBAD07Q55515010-8D8129A5-C62F-47D7-A51F-7EC7DBDFBCED
P2860
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@ast
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@en
type
label
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@ast
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@en
prefLabel
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@ast
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@en
P2093
P2860
P356
P1476
Tacrolimus (FK506) and methotr ...... eic stem cell transplantation.
@en
P2093
Hutchinson RJ
Ratanatharathorn V
P2860
P2888
P304
P356
10.1038/SJ.BMT.1702472
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1051687009